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Coronary calcium scoring: are the results
comparable to computed tomography coronary
angiography for screening coronary artery disease
in a South Asian population?
Nizar Bhulani1, Ali Khawaja2*, Asif Jafferani3, Maryam Baqir2, Ramin Ebrahimi4 and Zafar Sajjad5

Abstract
Background: The need of having feasible screening tools like Coronary Calcium Scoring (CCS) and CT Coronary
Artery (CTCA) for Coronary Artery Disease (CAD) has become paramount. We aimed to evaluate the accuracy of
CCS in determining the degree of stenosis of coronary vessels as compared to that determined by CTCA in a South
Asian population.
Methods: A retrospective study was conducted at The Aga Khan University Hospital. A total of 539 patient records
were reviewed who had undergone CCS and CTCA between 2008 and 2010. Patient records were reviewed by
comparing their CCS and CTCA results.
Results: About 268 out of 301 (89%) patients with a CCS of 0–9 were found to be free of stenosis on CTCA. On a
CCS of 10–99, 110 out of 121 (91%) patients were either free of stenosis or had mild stenosis. About 66 out of 79
(84%) patients had moderate or severe stenosis with a calcium score of 100–400 while none of the patients were
free of stenosis. Around 28 out of 38 (74%) patients with a CCS of more than 400 had severe stenosis. However,
only 04 patients (11%) were found to have mild stenosis. Spearman’s rho revealed a correlation coefficient of 0.791
with a p-value of <0.001.
Conclusion: Our study reaffirms that in South Asian population, low CCS (<100) is associated with no or minimal
stenosis while high CCS warrants further investigation; hence, making it a reliable tool for screening patients with
CAD.
Keywords: Coronary calcium scoring, CT Coronary artery, Coronary artery disease, Stenosis, Pakistan, South Asia

Background
South Asian population is regarded as one of the most
susceptible populations to coronary artery disease (CAD)
[1]. Already an important cause of morbidity and mortality
in developed countries, CAD has started taking its toll on
developing countries as well. Mohan et al. reported an
overall prevalence of 11% of CAD in a native urban South
Indian population whereas Jafar et al. reported around
27% people to be suffering from CAD in Karachi, Pakistan
[2,3]. This necessitates the development of better techniques for evaluation of the disease that are feasible with
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minimal invasiveness and side effects, in order to facilitate
early interventions.
Recent progress in imaging techniques has given us
the liberty to assess the development and progression of
CAD. The advent of computed tomography coronary
angiography (CTCA) has increased our knowledge regarding the pathophysiology of CAD [4]. It is a beneficial, non-invasive technique that promises a high degree
of accuracy in ruling out CAD. With high feasibility and
little procedural risk, CTCA represents a reliable and
swift method of directly identifying the extent and severity of coronary artery stenosis [5,6]. Visualization and
evaluation of the coronary artery anatomy, morphology
and lesions have been made more convenient by this
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technique with the help of a higher temporal and spatial
resolution [4]. Though it may not provide the degree of
image quality and diagnostic accuracy compared to invasive coronary angiography, its sensitivity and specificity of 97.4% and 97.8%, respectively with positive
predictive value and negative predictive value of 92.2%
and 100%, respectively along with a diagnostic accuracy
of 96.5% is impressive [7].
Another imaging modality, coronary calcium scoring
(CCS) may serve as a strong indicator of cardiac pathological processes such as atherosclerosis which can be
measured either by fast electron beam computed tomography (EBCT) or multi-detector computerized tomography (MDCT) [8]. It provides an indication of coronary
plaque load and allows risk stratification in patients [9].
Such has been its impact that it has been regarded to be
more sensitive and specific in estimating the risk of
coronary events than the conventional Framingham risk
score [10]. Moreover, a study found a progressive increase in the adjusted risk score of coronary events with
simultaneous increase in calcium score in four racial
groups [11].
CCS is a relatively cheaper modality with decreased
exposure to radiation as compared to CTCA. Hence, it
could be used as a more feasible screening tool in patients with CAD. However, data comparing the extent to
which the results of CTCA and CCS complement each
other remain scarce in the South Asian population. We
aimed to evaluate the accuracy of CCS in determining the
degree of stenosis of coronary vessels as compared to that
determined by CTCA in a South Asian population.

Methods
The study was carried out at the Department of Radiology,
The Aga Khan University Hospital (AKUH), Karachi.
AKUH is a major tertiary care hospital serving more
than 10 million people of Karachi and the surrounding
region. With an operational strength of 650 beds, the
facility serves over 42,000 inpatients and over 500,000
outpatients annually. Established since 1985, it is one
of the few teaching hospitals in South Asia accredited
by the Joint Commission for International Accreditation [12]. A retrospective study design was conducted
in which the medical record numbers of patients who
had undergone CTCA and CCS were obtained.
Inclusion and exclusion criteria

All the patients undergoing both CTCA and CCS
between February 2008 and February 2010 were included
in the study. No patients were excluded.
Scans for the procedures had been acquired on a
Toshiba Aquilion 64-row detector computerized tomography scanner (Toshiba Medical Systems, Japan) using
cardiac gating. All the scans were read by two professional
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radiologists separately and the final result was documented. The procedures were carried out as below:
Coronary calcium score

After obtaining informed consent, a non contrast scan
extending from the pulmonary hilum to the base of the
heart was obtained in a single breath hold. Volume data
was reconstructed in 3 mm axial images. This data was
then transferred to a Vitrea 2 Workstation (Vital Images,
USA). The coronary artery calcium was manually tagged.
The calcium score was calculated using the Agaston system of scoring [13].
Computed tomography coronary angiography

The indications for CTCA included presence of chest
pain and risk factors for CAD, positive (or equivocal)
stress test, preoperative assessment prior to valve surgery,
evaluation for cardiomyopathy and screening for CAD.
After obtaining informed consent, the patients’ renal
function were pre-assessed by serum creatinine levels
and they were asked to abstain from caffeine, tobacco
and other stimulants for 24 hours prior to the scan. The
patients were pre-treated with an oral beta-blocker;
Metoprolol 50 mg 12 hours and 2 hours prior to the
scan while calcium channel blockers were substituted if
there were any standard beta-blocker contraindications
to target an optimal heart rate for the scans in the range
of 55–65 beats per minute. Intra venous access was
obtained in the ante-cubital fossa with a 20G cannula.
80 mLs of non-ionic contrast containing 350 mg of
Iodine/mL was injected at a rate of 4 mLs/sec followed
by 40 mLs of normal saline. Scan was obtained in single
breath hold from the pulmonary hilum to the base of
the heart. The data was retrospectively gated and
reconstructed at 70, 80 and 30% of the RR interval.
Further reconstructions were carried out as required to
assess individual segments. Data was transferred to a
Vitrea 2 workstation (Vital Images USA) for analysis.
Age, gender, degree of coronary stenosis as obtained
through the CTCA and calcium score of the subject as
obtained from the CCS were acquired from the records.
The classification of degree of stenosis was as follows;
mild <30%, moderate 30-60% and severe > 60%. Risk
factors for developing CAD like smoking, fasting lipid
levels, family history of CAD etc. were not evaluated.
The data was entered and analyzed using Statistical
package for social science (SPSS 19.0 copyright © SPSS;
1989–02). Descriptive analysis was carried out for the
data. The degree of stenosis was divided into four
groups namely i) free of stenosis ii) mild iii) moderate
and iv) severe, whereas calcium scores were divided
into ranges of i) 0–9 ii) 10–99 iii) 100–400 and iv) > 400.
As the data was non parametric, Spearman’s rho was
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performed to assess the correlation between the degree of
stenosis and calcium scores.
Ethical approval

Due to the retrospective nature of the study, a written
informed consent could not be obtained from the participants. However, identification of the study participants
was kept strictly confidential and approval was taken by
the Ethics Review Committee of the Aga Khan University
Hospital prior to commencement of the study.

Table 2 Frequency analysis showing the comparison
between the degree of stenosis and groups of coronary
calcium scoring
Calcium score

Degree of stenosis

Number of patients (%)

0-9

Free of stenosis

268(89.0)

Mild

10(3.3)

Moderate

7(2.3)

Severe

16(5.3)

10-99

Results
A total of 539 patients were reviewed retrospectively.
The mean age was 50.8 ± 10.3 years, 389 (72%) patients
were males (Table 1).
100-400

Total

301(100)

Free of stenosis

21(17.4)

Mild

89(73.6)

Moderate

9(7.4)

Severe

2(1.7)

Total

121(100)

Mild

13(16.5)

Calcium score at different levels of the degree of stenosis

Moderate

43(54.4)

It was found that 268 (89%) out of 301 patients with a
calcium score of 0–9 were free of stenosis on CTCA
while only 8% had moderate to severe stenosis.
In patients with a calcium score of 10–99, majority
(91%) were either free of stenosis or had mild stenosis.
The remaining patients had either moderate or severe
stenosis.
In patients with calcium score between 100–400, more
than half of the patients; 55% had moderate stenosis
while none of the patients were free of stenosis. However, about 29% of the patients were affected with severe
stenosis.
In patients with a calcium score of > 400, approximately three quarters of them (74%) had severe stenosis.
However, only 11% of patients were found to have mild
stenosis. Table 2 summarizes the frequency analysis between calcium scores and degree of stenosis. Spearman’s
rho revealed a correlation coefficient of 0.791 with a
p-value of < 0.001.

Severe

23(29.1)

Total

79(100)

Mild

4(10.5)

Moderate

6(15.8)

Table 1 Frequency analysis of patients undergoing
computed tomography coronary angiography and
coronary calcium scoring
Degree of stenosis on computed tomography Number of patients
coronary angiography
(%)
Free of stenosis

289 (54)

Mild

116 (21)

Moderate

65 (12)

Severe

69 (13)

Coronary Calcium Score
0-9

301 (56)

10-99

121 (22)

100-400

79 (15)

>400

38 (7)

>400

Severe

28(73.7)

Total

38(100)

Discussion
Advances in the imaging modalities in the last decades
have raised the expectations of patients to have access to
simpler and non-invasive techniques to reach a diagnosis. CTCA is being increasingly used as both, a screening
and a diagnostic modality whereas CCS is mainly used
for the purpose of risk stratification. CCS is highly cost
effective and if accurate in predicting the degree of stenosis, may reduce the number of patients referred for
diagnostic procedures lowering the cost burden. Hence,
there was a need to compare CTCA and CCS as screening modalities.
CTCA is a non-invasive radiological procedure that allows obtaining quick images with a higher temporal and
spatial resolution. It allows direct visualization and
evaluation of the coronary artery anatomy, morphology
and any lesions within [4]. Moreover, a high degree of
accuracy has been validated in identifying the extent
and severity of coronary artery stenosis [7]. CCS, on the
other hand is an established marker for atherosclerosis
and a predictor of cardiac events. It is used to locate and
quantify coronary artery calcification [9,14]. A higher
score predicts higher plaque burden and a greater chance
of cardiac events. CCS is better suited to identify patients
with disease rather than to rule out disease or to localize it
to particular arterial segments [15] while diagnostically,
CTCA’s supremacy has been proven in ruling out disease
where CCS has been proven to be inadequate [16,17].
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CTCA, however, is a modality which is not free of risks.
High doses of X-ray radiations particularly in women and
young patients are a serious concern which could lead to
serious long-term effects [18]. Keeping the adverse effects
in mind, it has been reported that due to low probability
in finding non-calcified plaques in the subgroup of
negative CCS, CTCA might not always be justified [19].
Keeping this in mind, modalities with fewer side effects
like CCS must be brought into practice and justified to
screen for CAD; which paved way for this study. The
main outcome of this study suggests that increasing
CCS correlates with the severity of CAD. However, it
also confirms that the extremes of CCS do not necessarily
rule out or rule in severe CAD.
In the present study, CTCA showed 89% of the
patients to be free of stenosis with a CCS of 0–9. This is
consistent with the studies carried out by Werkhoven
et. al and Lau et. al who reported 80% and 84% of the
patients having no stenosis with a CCS of 0 respectively
[15,20]. However, around 5% of our patients in this sub
group had severe stenosis. Werkhoven et.al observed
significant CAD in 4% of patients with a CCS of 0 compared to 8% detected by Cademartiri et al. and Akram
et al. [16,20,21]. Presence of stenosis in the absence of
CCS is due to early atherosclerosis which contains
lipid-rich plaques which have not calcified. These plaques
are proven to be more susceptible to rupture as compared
to relatively stable calcium plaques [22,23] making it
essential to diagnose and locate them as early as
possible. Having said that, histological analysis remains
superior to all other modalities [15]. However, its utility
in clinical practice remains limited.
In the present study, CCS between 10 and 99 was
highly associated with either no or mild stenosis. The
intermediate CCSs, on the other hand were less conclusive. Although 54% of the patients with 100–400 CCS
had moderate stenosis, 29% had severe disease. Leber,
in one of his reviews, mentioned that scores that fall in
the intermediate percentiles are not statistically significant
[24]. On the other extreme of CCS of > 400; however,
the percentage of severe stenosis was the highest at
73.7%. This association, between a high CCS and increased severity in stenosis, is corresponding to the
literature which suggests that there is a significantly
higher chance of cardiac events in this subgroup of
patients [11,15,19,25]. Lau et. al reported that a CCS
greater than or equal to 400 increased the sensitivity of
CTCA from 93% to 100% [15]. Hence, it may help diagnose disease that is not detected at CT angiography.
A factor which cannot be ignored particularly in the
developing countries like Pakistan, is cost effectiveness
and patient’s feasibility, hence the need of better application of CCS as a screening modality if CTCA could not
be afforded by the patient.
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Limitations

Some limitations of the study need to be addressed.
Firstly, there were an unequal number of patients in
different groups stratified on the basis of CCS. However,
this difference was inherent in this study being a retrospective analysis of the hospital data. Secondly, our study
did not take into account the demographics and other
risk factors which define the cardiovascular profile of
the patients. This also was not that relevant to the study
question and; therefore, a more comprehensive study
can be designed which can include the above with the
screening modalities. This would enable a risk score
based on these risk factors along with CCS to be generated for the South Asian population on the lines of the
Framingham risk score, which would further help in risk
stratification of patients with suspected CAD. Thirdly,
this study was not designed to calculate the sensitivity,
specificity and positive and negative predictive values for
CCS. Lastly, we compared CCS as a screening modality
to CTCA and not the invasive coronary angiography
which is considered the gold standard for diagnosing
CAD.

Conclusion
The complementary use of CTCA and CCS provides an
optimal diagnosis in stenosis detection. A rise in CCS
levels simultaneously raises the probability of significant
CAD and presents a good and feasible alternative screening modality. It is also emphasized that absence of CCS
does not necessarily rule out a disease and vice versa.
Our study reaffirms in the South Asian population that
low CCS (<100 in our study) is highly indicative of no
or minimal stenosis. In this subgroup, further workup
should only be carried out in high risk patients. On the
other hand, a high CCS in most cases warrants further
investigations such as CTCA or invasive coronary angiography to reach a confirmatory diagnosis.
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